CERRITOS, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate at the following investor conferences: Jefferies Global Healthcare ConferenceDate: June 6th, 2024Fireside Chat: 9:00am Eastern TimeTOI Participant: Daniel Virnich, M.D., MBA, Chief Executive OfficerLocation: New York City, NY Truist Securities Health
CERRITOS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) have announced their executives’ participation in multiple panel presentations at the upcoming APG 2024 Spring Conference in San Diego. Chief Medical Officer, Dr. Yale Podnos, will be discussing artificial intelligence and its uses in an oncology practice in the breakout session panel “AI on the Front Lines: Improving Outcomes and Reducing Costs for Complex Patients”. Dr. Danie
TOI reports a robust revenue increase and strategic expansions, counterbalanced by margin pressures and operational losses in the first quarter of 2024.